MIRM
Mirum Pharmaceuticals Inc
80.60$
+1.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | -54.5% | -37.2% | +310.8% | +35.6% | +7.4% | +48.6% | +13.2% | +18.7% | +27.3% | +45.7% | -0.5% | +12.5% | +16.1% | +10.0% | +12.2% | +14.5% | +4.1% | +12.0% | +7.4% | +10.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +27.4% | +4.1% | +16.2% | +53.3% | +10.8% | +36.8% | +50.1% | +144.6% | -28.7% | +13.4% | +2.9% | +9.5% | +1.0% | +1.8% | +9.0% | +11.0% | +1.9% | +5.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -54.5% | -75.3% | +747.6% | +42.9% | +5.9% | +47.7% | +13.7% | +15.3% | +22.2% | +18.8% | +15.4% | +12.2% | +20.7% | +10.2% | +15.6% | +17.8% | +3.0% | +12.2% | +8.6% | +11.4% | – | |
| – | +840,850.0% | -80.7% | +138.3% | +4.9% | +18.3% | +20.6% | +7.0% | -13.9% | +86.0% | +28.3% | -8.1% | -13.1% | -8.8% | -13.3% | +5.6% | +3.1% | +18.6% | -24.3% | -6.5% | +18.7% | +18.4% | +4.2% | +1.4% | -2.9% | +38.8% | +4.6% | +0.0% | -6.7% | +19.0% | +91.6% | -7.5% | – | |
| – | +1,199.2% | +64.0% | +85.1% | +51.7% | +15.4% | +9.7% | +7.5% | +13.7% | +26.0% | +31.2% | +40.9% | +30.0% | +9.7% | +0.4% | +9.7% | +7.4% | -24.7% | +78.2% | +9.0% | +10.9% | +9.2% | +14.4% | -9.6% | +22.6% | -10.3% | +27.3% | +9.7% | -2.2% | +19.7% | +30.0% | -15.4% | – | |
| – | +39,952.3% | -76.2% | +126.9% | +13.1% | +17.6% | +18.1% | +7.1% | -8.0% | +70.2% | +28.9% | +1.7% | -1.2% | -2.1% | -7.7% | +7.4% | +5.0% | +18.1% | -6.6% | +2.2% | +14.0% | +23.1% | +1.0% | +5.2% | +0.5% | +22.6% | +2.9% | +5.4% | -4.1% | +19.4% | +55.1% | -3.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -275.5% | – | – | – | |
| – | – | – | – | – | -99.4% | +14,880.0% | -45.9% | -41.5% | +41.4% | +909.3% | +41.3% | +18.7% | -33.5% | +0.2% | +2.7% | +2.5% | +9.8% | -2.7% | -12.2% | -4.1% | -0.3% | +0.4% | -0.2% | +0.5% | -0.2% | +0.5% | -0.2% | +0.5% | -0.2% | +0.5% | -27.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -163.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -287.8% | – | – | – | |
| – | – | – | -301.7% | – | – | -81.0% | -25.0% | -200.0% | – | +150.0% | +120.0% | -18.2% | +33.3% | -8.3% | -59,827.3% | – | +976.9% | +43.6% | +57.2% | -21.2% | -9.6% | +177.3% | +1.8% | -45.4% | -266.0% | – | -60.9% | -165.2% | – | -38.1% | +255.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -163.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -297.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -152.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | +116.4% | -48.0% | -16,646.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.